Christos Hatzis

12.4k total citations · 2 hit papers
162 papers, 7.1k citations indexed

About

Christos Hatzis is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Christos Hatzis has authored 162 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Cancer Research, 57 papers in Molecular Biology and 51 papers in Oncology. Recurrent topics in Christos Hatzis's work include Cancer Genomics and Diagnostics (42 papers), Breast Cancer Treatment Studies (38 papers) and HER2/EGFR in Cancer Research (22 papers). Christos Hatzis is often cited by papers focused on Cancer Genomics and Diagnostics (42 papers), Breast Cancer Treatment Studies (38 papers) and HER2/EGFR in Cancer Research (22 papers). Christos Hatzis collaborates with scholars based in United States, Greece and Germany. Christos Hatzis's co-authors include Lajos Pusztai, W. Fraser Symmans, Gabriel N. Hortobágyi, Vicente Valero, Florentia Peintinger, Aman U. Buzdar, Henry M. Kuerer, Bryan T. Hennessy, S. Eva Singletary and Anna W. Poniecka and has published in prestigious journals such as JAMA, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Christos Hatzis

154 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy

2007 1.1k citations W. Fraser Symmans, Florentia Peintinger et al. profile →
Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype

2017 417 citations W. Fraser Symmans, Rebekah Gould et al. profile →

Peers

Countries citing papers authored by Christos Hatzis

Since Specialization

Citations

This map shows the geographic impact of Christos Hatzis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christos Hatzis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christos Hatzis more than expected).

Fields of papers citing papers by Christos Hatzis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christos Hatzis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christos Hatzis. The network helps show where Christos Hatzis may publish in the future.

Co-authorship network of co-authors of Christos Hatzis

This figure shows the co-authorship network connecting the top 25 collaborators of Christos Hatzis. A scholar is included among the top collaborators of Christos Hatzis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christos Hatzis. Christos Hatzis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessment of stained direct cytology smears of breast cancer for whole transcriptome and targeted messenger RNA sequencing 2023 ·Cancer Cytopathology ·Michał Marczyk, Chunxiao Fu, Rosanna Lau, Lili Du, (unknown), Bruno V. Sinn, Rebekah Gould, Lajos Pusztai, Christos Hatzis, W. Fraser Symmans	4
2	Targeted RNAseq assay incorporating unique molecular identifiers for improved quantification of gene expression signatures and transcribed mutation fraction in fixed tumor samples 2021 ·BMC Cancer ·Chunxiao Fu, Michał Marczyk, Michael L. Samuels, (unknown), Jiaxin Qu, Rosanna Lau, Lili Du, Todd C. Pappas, Bruno V. Sinn, Rebekah Gould, Lajos Pusztai, Christos Hatzis, W. Fraser Symmans	6
3	Analysis of Pre- and Posttreatment Tissues from the SWOG S0800 Trial Reveals an Effect of Neoadjuvant Chemotherapy on the Breast Cancer Genome 2020 ·Clinical Cancer Research ·Ryan L. Powles, Vikram B. Wali, Xiaotong Li, William E. Barlow, Zeina Nahleh, Alastair M. Thompson, Andrew K. Godwin, Christos Hatzis, Lajos Pusztai	9
4	Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells 2020 ·Cancers ·Michał Marczyk, Gauri A. Patwardhan, Jun Zhao, Rihao Qu, Xiaotong Li, Vikram B. Wali, Abhishek Gupta, Manoj M. Pillai, Yuval Kluger, Qin Yan, Christos Hatzis, Lajos Pusztai, Vignesh Gunasekharan	15
5	Germline variant burden in cancer genes correlates with age at diagnosis and somatic mutation burden 2020 ·Nature Communications ·Tao Qing, Hussein Mohsen, Michał Marczyk, Yixuan Ye, Tess A. O’Meara, Hongyu Zhao, Jeffrey P. Townsend, Mark Gerstein, Christos Hatzis, Yuval Kluger, Lajos Pusztai	49
6	Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer 2019 ·Scientific Reports ·Vikram B. Wali, Gauri A. Patwardhan, Vasiliki Pelekanou, Thomas Karn, Jian Cao, Alberto Ocaña, Qin Yan, Bryce Nelson, Christos Hatzis, Lajos Pusztai	18
7	The impact of RNA extraction method on accurate RNA sequencing from formalin-fixed paraffin-embedded tissues 2019 ·BMC Cancer ·Michał Marczyk, Chunxiao Fu, Rosanna Lau, Lili Du, (unknown), Bruno V. Sinn, Rebekah Gould, Lajos Pusztai, Christos Hatzis, W. Fraser Symmans	41
8	Breast cancer patients with brain metastasis undergoing GKRS 2018 ·Breast Cancer ·Maysa Abu‐Khalaf, (unknown), Christos Hatzis, (unknown), James B. Yu, Veronica Chiang	6
9	Immune Gene Expression Is Associated with Genomic Aberrations in Breast Cancer 2017 ·Cancer Research ·Anton Safonov, Tingting Jiang, Giampaolo Bianchini, Balázs Győrffy, Thomas Karn, Christos Hatzis, Lajos Pusztai	108
10	Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor 2017 ·Molecular Cancer Therapeutics ·Casey G. Langdon, James T. Platt, Robert E. Means, (unknown), Ramanaiah Mamillapalli, (unknown), Matthew A. Held, Jong Woo Lee, Ja Seok Koo, Christos Hatzis, Howard S. Höchster, David F. Stern	12
11	Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast Cancer 2016 ·Cancer Research ·Vikram B. Wali, Casey G. Langdon, Matthew A. Held, James T. Platt, Gauri A. Patwardhan, Anton Safonov, Bilge Aktaş, Lajos Pusztai, David F. Stern, Christos Hatzis	38
12	Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast Cancer 2016 ·Clinical Cancer Research ·(unknown), Kirsten M. Timms, Anees B. Chagpar, Vikram B. Wali, Tingting Jiang, Veerle Bossuyt, Ozlen Saglam, Julia Reid, Alexander Gutin, Chris Neff, Jerry S. Lanchbury, Christos Hatzis, Erin Hofstatter, Lajos Pusztai	26
13	Relationship between Complete Pathologic Response to Neoadjuvant Chemotherapy and Survival in Triple-Negative Breast Cancer 2015 ·Clinical Cancer Research ·Christos Hatzis, W. Fraser Symmans, Ya Zhang, Rebekah Gould, Stacy Moulder, Kelly K. Hunt, Maysa Abu‐Khalaf, Erin Hofstatter, Donald R. Lannin, Anees B. Chagpar, Lajos Pusztai	44
14	Gene Signature–Guided Dasatinib Therapy in Metastatic Breast Cancer 2014 ·Clinical Cancer Research ·Lajos Pusztai, Stacy L. Moulder, Mehmet Altan, Danielle Kwiatkowski, Vicente Valero, Naoto T. Ueno, Francisco J. Esteva, Rony Avritscher, Yuan Qi, Lewis C. Strauss, Gabriel N. Hortobágyi, Christos Hatzis, W. Fraser Symmans	28
15	Enhancing Reproducibility in Cancer Drug Screening: How Do We Move Forward? 2014 ·Cancer Research ·Christos Hatzis, Philippe L. Bédard, Nicolai J. Birkbak, Andrew H. Beck, Hugo J.W.L. Aerts, David F. Stern, Leming Shi, Robert Clarke, John Quackenbush, Benjamin Haibe‐Kains	67
16	Development of Candidate Genomic Markers to Select Breast Cancer Patients for Dasatinib Therapy 2010 ·Molecular Cancer Therapeutics ·Stacy Moulder, Kai Yan, Fei Huang, Kenneth R. Hess, Cornelia Liedtke, Feng Lin, Christos Hatzis, Gabriel N. Hortobágyi, W. Fraser Symmans, Lajos Pusztai	27
17	Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab 2008 ·Annals of Oncology ·Florentia Peintinger, Aman U. Buzdar, Henry M. Kuerer, Jaime Mejia, Christos Hatzis, Ana M. González-Angulo, Lajos Pusztai, Francisco J. Esteva, Shaheenah Dawood, (unknown), Gabriel N. Hortobágyi, W. Fraser Symmans	34
18	Microtubule-Associated Protein-tau is a Bifunctional Predictor of Endocrine Sensitivity and Chemotherapy Resistance in Estrogen Receptor–Positive Breast Cancer 2007 ·Clinical Cancer Research ·Fabrice André, Christos Hatzis, K. Anderson, Christos Sotiriou, Chafika Mazouni, Jaime Mejia, Bailiang Wang, Gabriel N. Hortobágyi, W. Fraser Symmans, Lajos Pusztai	100
19	Vav3, a Rho GTPase guanine nucleotide exchange factor, represents a potential novel therapeutic target for breast cancer 2007 ·Cancer Research ·Fabrice André, (unknown), Christos Hatzis, Ludovic Lacroix, Chafika Mazouni, Christos Sotiriou, (unknown), Stacy Moulder, Lajos Pusztai	1
20	Measurements of estrogen receptor and reporter genes from microarrays determine receptor status and time to recurrence following adjuvant tamoxifen therapy. 2005 ·Breast Cancer Research and Treatment ·W. Fraser Symmans, Christos Sotiriou, Steve Anderson, Christos Hatzis, Vicente Valero, (unknown), Denis Larsimont, Christine Desmedt, David Gold, Nour Sneige, (unknown), (unknown), Yun Yun Gong, Jeff Ross, Kathryn Hess, Martine Piccart, Adrian L. Harris, G. N. Hortobágyi, Lajos Pusztai	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact